Section of Digestive Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT 06510, United States.
Department of Pathology, Yale University School of Medicine, New Haven, CT 06510, United States.
World J Gastroenterol. 2021 Apr 21;27(15):1630-1642. doi: 10.3748/wjg.v27.i15.1630.
Recurrent acute pancreatitis (RAP) may be a presenting feature of and an indication for resection of pancreatic cysts, including intra-ductal papillary mucinous neoplasm (IPMN). Few data are available regarding the prevalence of malignancy and post-operative RAP in this population.
To study the role of resection to help prevent RAP and analyze if presentation as RAP would be a predictor for malignancy.
This retrospective study assessed 172 patients who underwent surgical resection of pancreatic cystic neoplasms at a university hospital between 2002 and 2016. The prevalence of preoperative high-risk cyst features, and of neoplasia was compared between patients with and without RAP. To identify the cause of pancreatitis, all the patients had a detailed history of alcohol, smoking, medications obtained, and had cross-sectional imaging (contrast-enhanced computed tomography/magnetic resonance imaging) and endoscopic ultrasound to look for gallstone etiology and other structural causes for pancreatitis. The incidence of RAP post-resection was the primary outcome.
IPMN accounted for 101 cases (58.7%) {[branch duct (BD) 59 (34.3%), main duct (MD) 42] (24.4%)}. Twenty-nine (16.9%) presented with RAP (mean 2.2 episodes): 15 had BD-IPMN, 8 MD-IPMN, 5 mucinous cystic neoplasm and 1 serous cystic neoplasm. Malignancy was similar among those with without RAP for all patients [6/29 (20.7%) 24/143 (16.8%)] and IPMN patients [6/23 (26.1%) 23/78 (29.5%)], although tended to be higher with RAP in BD-IPMN, [5/15 (33.3%) 3/44 (6.8%), = 0.04]. At mean follow-up of 7.2 years, 1 (3.4%) RAP patient had post-resection RAP. The mean episodes of acute pancreatitis before after surgery were 3.4 0.02 ( < 0.0001).
Malignancy was not increased in patients with pancreatic cystic neoplasms who have RAP compared to those without RAP. In addition, specific cyst charac-teristics were not clearly associated with RAP. The incidence of RAP was markedly decreased in almost all patients following cyst resection.
复发性急性胰腺炎(RAP)可能是胰腺囊肿切除的表现和指征,包括导管内乳头状黏液性肿瘤(IPMN)。关于该人群中恶性肿瘤的患病率和术后 RAP,目前数据有限。
研究切除的作用,以帮助预防 RAP,并分析 RAP 是否为恶性肿瘤的预测指标。
这项回顾性研究评估了 2002 年至 2016 年间在一所大学医院接受胰腺囊性肿瘤切除术的 172 名患者。比较了 RAP 患者与无 RAP 患者术前高危囊肿特征和肿瘤发生率。为了确定胰腺炎的病因,所有患者均详细询问了酒精、吸烟、用药史,并进行了横断面成像(增强 CT/MRI)和内镜超声检查,以寻找胆石病因和其他引起胰腺炎的结构原因。术后 RAP 的发生率为主要结局。
IPMN 占 101 例(58.7%){[分支胰管(BD)59 例(34.3%),主胰管(MD)42 例](24.4%)}。29 例(16.9%)表现为 RAP(平均 2.2 次发作):15 例为 BD-IPMN,8 例为 MD-IPMN,5 例为黏液性囊腺瘤,1 例为浆液性囊腺瘤。所有患者中,有 RAP 与无 RAP 的患者恶性肿瘤发生率相似[6/29(20.7%)24/143(16.8%)]和 IPMN 患者[6/23(26.1%)23/78(29.5%)],尽管 BD-IPMN 中 RAP 倾向于更高[5/15(33.3%)3/44(6.8%),=0.04]。在平均 7.2 年的随访中,1 例(3.4%)RAP 患者术后发生 RAP。术前和术后急性胰腺炎发作的平均次数分别为 3.4 和 0.02(<0.0001)。
与无 RAP 的患者相比,患有 RAP 的胰腺囊性肿瘤患者的恶性肿瘤发生率并未增加。此外,特定的囊肿特征与 RAP 无明显关联。几乎所有患者在接受囊肿切除术后 RAP 的发生率均明显降低。